Andrea Arciniegas-Moreno

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cardiac Surveillance for Anthracycline Cardiotoxicity: Clinical Yield in Low-to-Intermediate Risk Patients: MATRIX Study.

Cardiac Surveillance for Anthracycline Cardiotoxicity: Clinical Yield in Low-to-Intermediate Risk Patients: MATRIX Study.

Journal: JACC. CardioOncology

Published: January 15, 2026

SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial Energetics.

SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial Energetics.

Journal: JACC. CardioOncology

Published: July 22, 2024

Cardioprotection strategies for anthracycline cardiotoxicity.

Cardioprotection strategies for anthracycline cardiotoxicity.

Journal: Basic research in cardiology

Published: June 11, 2024

Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors.

Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors.

Journal: JACC. Cardiovascular imaging

Published: April 17, 2024

Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.

Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.

Journal: European journal of heart failure

Published: April 02, 2024

Association between subclinical atherosclerosis burden and unrecognized myocardial infarction detected by cardiac magnetic resonance in middle-aged low-risk adults.

Association between subclinical atherosclerosis burden and unrecognized myocardial infarction detected by cardiac magnetic resonance in middle-aged low-risk adults.

Journal: European heart journal. Cardiovascular Imaging

Published: July 22, 2023

Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.

Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.

Journal: Diabetes care

Published: May 15, 2023

Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study.

Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study.

Journal: The lancet. Healthy longevity

Published: March 27, 2023

The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity.

The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity.

Journal: JACC. Basic to translational science

Published: February 07, 2022

Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters.

Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters.

Journal: ESC heart failure

Published: May 01, 2021

Coronary arterial segmental stenosis quantified by MDCT: correlation with quantitative coronary analyses by invasive angiography.

Coronary arterial segmental stenosis quantified by MDCT: correlation with quantitative coronary analyses by invasive angiography.

Journal: Revista espanola de cardiologia (English ed.)

Published: April 17, 2020

Additional value of hybrid PET/MR imaging versus MR or PET performed separately to assess cardiovascular disease.

Additional value of hybrid PET/MR imaging versus MR or PET performed separately to assess cardiovascular disease.

Journal: Revista espanola de cardiologia (English ed.)

Published: November 29, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026